DUBLIN--(BUSINESS WIRE)--Jul 13, 2018--The "Europe Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The research provides insights into Pancreatic Cancer epidemiology, Pancreatic Cancer diagnosed patients, and Pancreatic Cancer treatment rate for EU5 countries. The research measures key indicators including prevalence of Pancreatic Cancer derived from epidemiological analysis, patients diagnosed with Pancreatic Cancer, and patients treated with a drug therapy. The research study helps executives estimate Pancreatic Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The research provides estimates and forecasts of Pancreatic Cancer prevalence, Pancreatic Cancer diagnosis rate, and Pancreatic Cancer treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK. Key Topics Covered 1. Pancreatic Cancer: Disease Definition 2. Pancreatic Cancer Patient Flow in Europe 2A. Pancreatic Cancer Prevalence in Europe 2B. Pancreatic Cancer Diagnosed Patients in Europe 2C. Pancreatic Cancer Treated Patients in Europe 3. Pancreatic Cancer Patient Flow in Germany 3A. Pancreatic Cancer Prevalence in Germany 3B. Pancreatic Cancer Diagnosed Patients in Germany 3C. Pancreatic Cancer Treated Patients in Germany 4. Pancreatic Cancer Patient Flow in France 4A. Pancreatic Cancer Prevalence in France 4B. Pancreatic Cancer Diagnosed Patients in France 4C. Pancreatic Cancer Treated Patients in France 5. Pancreatic Cancer Patient Flow in Spain 5A. Pancreatic Cancer Prevalence in Spain 5B. Pancreatic Cancer Diagnosed Patients in Spain 5C. Pancreatic Cancer Treated Patients in Spain 6. Pancreatic Cancer Patient Flow in Italy 6A. Pancreatic Cancer Prevalence in Italy 6B. Pancreatic Cancer Diagnosed Patients in Italy 6C. Pancreatic Cancer Treated Patients in Italy 7. Pancreatic Cancer Patient Flow in UK 7A. Pancreatic Cancer Prevalence in UK 7B. Pancreatic Cancer Diagnosed Patients in UK 7C. Pancreatic Cancer Treated Patients in UK 8. Research Methodology For more information about this report visit https://www.researchandmarkets.com/research/pw9dzh/europe_pancreatic?w=4

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005199/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pancreatic Cancer Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/13/2018 08:43 AM/DISC: 07/13/2018 08:43 AM

http://www.businesswire.com/news/home/20180713005199/en